Project archive

Starting in January 2019, 13 partners from 7 European countries, including research institutes, universities and small and medium-sized enterprises, have been collaborating in the Horizon 2020 project MDOT (Medical Device Obligations Taskforce). This project is being coordinated by Fraunhofer ITEM, with a grant size of 8.3 million euros and 5 years overall duration.

The RealWorld4Clinic project consortium develops a medical multi-sensor system (MySentinel) that will enable high-quality collection of real-life cardiorespiratory health data.

Researchers of the Fraunhofer ITEM have developed a system that optically detects neonatal breathing and releases the aerosol directly at the patient interface in a breath-triggered manner.

The focus of the Fraunhofer ITEM researchers in the ImmunAvatar project is on mimicking IBD. The use of both healthy tissue and tissue from IBD patients enables the identification of disease-specific differences, which can also be modulated in the model.

The Fraunhofer project FibroPaths® aims to enable rapid and safe development of antifibrotic drugs.

The aim of the MyCellFight project is to develop a fully automated immune chip able to predict the specific immune responses of individuals.

Together with several industry partners, Fraunhofer ITEM scientists published novel data on neoepitope biomarkers of type I, III and VI collagen formation or degradation in precision-cut lung slices (PCLS) from patients with Pulmonary fibrosis.

Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

Study on the toxicity of carbon fibers: influence of fiber rigidity and diameter on mesothelioma risk and asbestos-like effects.

Brain regeneration in focus: REGENERAR develops epigenetic tools to convert cells into functional neurons for innovative therapies.